159 related articles for article (PubMed ID: 34313294)
21. The roles of lipids in SARS-CoV-2 viral replication and the host immune response.
Theken KN; Tang SY; Sengupta S; FitzGerald GA
J Lipid Res; 2021; 62():100129. PubMed ID: 34599996
[TBL] [Abstract][Full Text] [Related]
22. COVID-19: Significance of antibodies.
Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
[TBL] [Abstract][Full Text] [Related]
23. Juggling the COVID-19 pandemic: A cytopathology point of view.
Iaccarino A; Pisapia P; Vigliar E; Vielh P; Troncone G
Cytopathology; 2021 May; 32(3):299-303. PubMed ID: 33145830
[TBL] [Abstract][Full Text] [Related]
24. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
Wei C; Wan L; Yan Q; Wang X; Zhang J; Yang X; Zhang Y; Fan C; Li D; Deng Y; Sun J; Gong J; Yang X; Wang Y; Wang X; Li J; Yang H; Li H; Zhang Z; Wang R; Du P; Zong Y; Yin F; Zhang W; Wang N; Peng Y; Lin H; Feng J; Qin C; Chen W; Gao Q; Zhang R; Cao Y; Zhong H
Nat Metab; 2020 Dec; 2(12):1391-1400. PubMed ID: 33244168
[TBL] [Abstract][Full Text] [Related]
25. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
Wu T; Zhang H; Hu E; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
Bilal M; Iqbal HMN
Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
[TBL] [Abstract][Full Text] [Related]
27. Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
Meoni G; Ghini V; Maggi L; Vignoli A; Mazzoni A; Salvati L; Capone M; Vanni A; Tenori L; Fontanari P; Lavorini F; Peris A; Bartoloni A; Liotta F; Cosmi L; Luchinat C; Annunziato F; Turano P
PLoS Pathog; 2021 Feb; 17(2):e1009243. PubMed ID: 33524041
[TBL] [Abstract][Full Text] [Related]
28. Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction.
Lodge S; Lawler NG; Gray N; Masuda R; Nitschke P; Whiley L; Bong SH; Yeap BB; Dwivedi G; Spraul M; Schaefer H; Gil-Redondo R; Embade N; Millet O; Holmes E; Wist J; Nicholson JK
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511373
[TBL] [Abstract][Full Text] [Related]
29. The role of post-transcriptional regulation in SARS-CoV-2 infection and pathogenicity.
Wang X; Chang Z; Zhao T; Zhong W; Shi J; Wang G; Xu X
Front Immunol; 2023; 14():1256574. PubMed ID: 38035086
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacokinetic changes related to acute infection. Examples from the SARS-CoV-2 pandemic].
Chavant A; Gautier-Veyret E; Chhun S; Guilhaumou R; Stanke-Labesque F
Therapie; 2021; 76(4):319-333. PubMed ID: 33129512
[TBL] [Abstract][Full Text] [Related]
31. Metabolic reprogramming and immune regulation in viral diseases.
Ganesh GV; Mohanram RK
Rev Med Virol; 2022 Mar; 32(2):e2268. PubMed ID: 34176174
[TBL] [Abstract][Full Text] [Related]
32. Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting the glycerophospholipid metabolism pathway.
Yan B; Yuan S; Cao J; Fung K; Lai PM; Yin F; Sze KH; Qin Z; Xie Y; Ye ZW; Yuen TT; Chik KK; Tsang JO; Zou Z; Chan CC; Luo C; Cai JP; Chan KH; Chung TW; Tam AR; Chu H; Jin DY; Hung IF; Yuen KY; Kao RY; Chan JF
Int J Biol Sci; 2022; 18(12):4744-4755. PubMed ID: 35874954
[TBL] [Abstract][Full Text] [Related]
33. A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants.
Farley SE; Kyle JE; Leier HC; Bramer LM; Weinstein JB; Bates TA; Lee JY; Metz TO; Schultz C; Tafesse FG
Nat Commun; 2022 Jun; 13(1):3487. PubMed ID: 35715395
[TBL] [Abstract][Full Text] [Related]
34. Controlling the Burden of COVID-19 by Manipulating Host Metabolism.
Miller L; Berber E; Sumbria D; Rouse BT
Viral Immunol; 2022; 35(1):24-32. PubMed ID: 34905407
[TBL] [Abstract][Full Text] [Related]
35. Functional and tissue enrichment analyses suggest that SARS-CoV-2 infection affects host metabolism and catabolism mediated by interference on host proteins.
Lopes LR
Braz J Microbiol; 2021 Sep; 52(3):1151-1159. PubMed ID: 33956332
[TBL] [Abstract][Full Text] [Related]
36. HDL and SARS CoV-2: emerging theragnostic implications.
Rani A; Stadler JT; Marsche G
Trends Mol Med; 2024 May; 30(5):425-428. PubMed ID: 38431503
[TBL] [Abstract][Full Text] [Related]
37. COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.
Cornillet M; Strunz B; Rooyackers O; Ponzetta A; Chen P; Muvva JR; Akber M; Buggert M; Chambers BJ; Dzidic M; Filipovic I; Gorin JB; Gredmark-Russ S; Hertwig L; Klingström J; Kokkinou E; Kvedaraite E; Lourda M; Mjösberg J; Maucourant C; Norrby-Teglund A; Parrot T; Perez-Potti A; Rivera-Ballesteros O; Sandberg JK; Sandberg JT; Sekine T; Svensson M; Varnaite R; ; Eriksson LI; Aleman S; Strålin K; Ljunggren HG; Björkström NK
Eur J Immunol; 2022 Mar; 52(3):503-510. PubMed ID: 34837225
[TBL] [Abstract][Full Text] [Related]
38. Metabolic Activation of PARP as a SARS-CoV-2 Therapeutic Target-Is It a Bait for the Virus or the Best Deal We Could Ever Make with the Virus? Is AMBICA the Potential Cure?
Puthanveetil P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830743
[TBL] [Abstract][Full Text] [Related]
39. Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: "Inflammatory Thrombosis with Immune Endotheliitis-ITIE".
Bilgin E; Ertenli Aİ
Rheumatol Int; 2021 Mar; 41(3):679-680. PubMed ID: 33388970
[No Abstract] [Full Text] [Related]
40. Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects.
D'Avila H; Lima CNR; Rampinelli PG; Mateus LCO; Sousa Silva RV; Correa JR; Almeida PE
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
